Tango Therapeutics (TNGX) Competitors $6.77 -0.09 (-1.31%) Closing price 07/18/2025 04:00 PM EasternExtended Trading$6.68 -0.09 (-1.26%) As of 07/18/2025 07:36 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock TNGX vs. IBRX, GMTX, ARWR, APLS, TWST, NAMS, APGE, RXRX, DNLI, and INDVShould you be buying Tango Therapeutics stock or one of its competitors? The main competitors of Tango Therapeutics include ImmunityBio (IBRX), Gemini Therapeutics (GMTX), Arrowhead Pharmaceuticals (ARWR), Apellis Pharmaceuticals (APLS), Twist Bioscience (TWST), NewAmsterdam Pharma (NAMS), Apogee Therapeutics (APGE), Recursion Pharmaceuticals (RXRX), Denali Therapeutics (DNLI), and Indivior (INDV). These companies are all part of the "pharmaceutical products" industry. Tango Therapeutics vs. Its Competitors ImmunityBio Gemini Therapeutics Arrowhead Pharmaceuticals Apellis Pharmaceuticals Twist Bioscience NewAmsterdam Pharma Apogee Therapeutics Recursion Pharmaceuticals Denali Therapeutics Indivior Tango Therapeutics (NASDAQ:TNGX) and ImmunityBio (NASDAQ:IBRX) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, analyst recommendations, institutional ownership, earnings, media sentiment, risk, dividends and valuation. Does the media refer more to TNGX or IBRX? In the previous week, Tango Therapeutics had 1 more articles in the media than ImmunityBio. MarketBeat recorded 2 mentions for Tango Therapeutics and 1 mentions for ImmunityBio. Tango Therapeutics' average media sentiment score of 0.54 beat ImmunityBio's score of 0.38 indicating that Tango Therapeutics is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Tango Therapeutics 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive ImmunityBio 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Do analysts rate TNGX or IBRX? Tango Therapeutics presently has a consensus price target of $10.50, suggesting a potential upside of 55.10%. ImmunityBio has a consensus price target of $12.25, suggesting a potential upside of 345.45%. Given ImmunityBio's stronger consensus rating and higher possible upside, analysts plainly believe ImmunityBio is more favorable than Tango Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Tango Therapeutics 0 Sell rating(s) 0 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 3.00ImmunityBio 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 1 Strong Buy rating(s) 3.20 Do institutionals & insiders have more ownership in TNGX or IBRX? 79.0% of Tango Therapeutics shares are held by institutional investors. Comparatively, 8.6% of ImmunityBio shares are held by institutional investors. 7.5% of Tango Therapeutics shares are held by company insiders. Comparatively, 76.8% of ImmunityBio shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Which has more risk & volatility, TNGX or IBRX? Tango Therapeutics has a beta of 1.63, indicating that its stock price is 63% more volatile than the S&P 500. Comparatively, ImmunityBio has a beta of 0.08, indicating that its stock price is 92% less volatile than the S&P 500. Is TNGX or IBRX more profitable? Tango Therapeutics has a net margin of -322.67% compared to ImmunityBio's net margin of -1,310.30%. ImmunityBio's return on equity of 0.00% beat Tango Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Tango Therapeutics-322.67% -62.75% -39.94% ImmunityBio -1,310.30%N/A -121.88% Which has better earnings and valuation, TNGX or IBRX? Tango Therapeutics has higher revenue and earnings than ImmunityBio. Tango Therapeutics is trading at a lower price-to-earnings ratio than ImmunityBio, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTango Therapeutics$42.07M17.44-$130.30M-$1.22-5.55ImmunityBio$14.74M164.67-$413.56M-$0.58-4.74 SummaryTango Therapeutics beats ImmunityBio on 9 of the 17 factors compared between the two stocks. Get Tango Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for TNGX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding TNGX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TNGX vs. The Competition Export to ExcelMetricTango TherapeuticsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$743.58M$2.95B$5.54B$9.40BDividend YieldN/A2.44%3.75%4.03%P/E Ratio-5.5519.7528.0119.79Price / Sales17.44298.31432.5697.34Price / CashN/A42.5936.1658.27Price / Book3.647.678.125.65Net Income-$130.30M-$55.28M$3.25B$257.91M7 Day Performance14.17%4.85%1.64%3.35%1 Month Performance41.04%11.70%7.27%11.09%1 Year Performance-26.97%3.69%32.88%18.99% Tango Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TNGXTango Therapeutics1.6621 of 5 stars$6.77-1.3%$10.50+55.1%-31.0%$743.58M$42.07M-5.5590IBRXImmunityBio2.2485 of 5 stars$2.72flat$12.25+350.4%-54.0%$2.40B$14.74M-4.69590Gap UpGMTXGemini TherapeuticsN/A$54.75+3.0%N/A+21.4%$2.37BN/A-54.7530ARWRArrowhead Pharmaceuticals3.8448 of 5 stars$16.84+0.3%$43.71+159.6%-39.4%$2.32B$545.21M-12.03400News CoveragePositive NewsAnalyst DowngradeAPLSApellis Pharmaceuticals4.3179 of 5 stars$17.42-4.6%$39.79+128.4%-48.7%$2.29B$781.37M-9.73770Trending NewsAnalyst ForecastInsider TradeAnalyst RevisionTWSTTwist Bioscience4.2161 of 5 stars$35.59-6.8%$50.40+41.6%-34.3%$2.29B$312.97M-10.95990News CoverageNAMSNewAmsterdam Pharma3.6061 of 5 stars$19.46-2.0%$42.89+120.4%+18.3%$2.23B$47.14M-10.354News CoverageAnalyst ForecastInsider TradeAPGEApogee Therapeutics3.0109 of 5 stars$39.24-17.3%$99.00+152.3%-17.3%$2.19BN/A-10.9091High Trading VolumeRXRXRecursion Pharmaceuticals1.2923 of 5 stars$4.93-6.5%$7.00+42.0%-25.8%$2.14B$58.84M-2.79400Gap UpHigh Trading VolumeDNLIDenali Therapeutics4.5952 of 5 stars$14.25-3.0%$33.71+136.6%-35.7%$2.13B$330.53M-5.34430INDVIndivior0.833 of 5 stars$15.55+0.9%$17.00+9.3%+53.1%$2.12B$1.17B-50.161,051Upcoming Earnings Related Companies and Tools Related Companies IBRX Competitors GMTX Competitors ARWR Competitors APLS Competitors TWST Competitors NAMS Competitors APGE Competitors RXRX Competitors DNLI Competitors INDV Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TNGX) was last updated on 7/19/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTurn $1K into $50K with This DeFi GemI've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tango Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Tango Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TNGX Stock Alerts